L&S Venture Capital
L&S Venture Capital is a Seoul-based venture capital firm established in 2006 that provides early-stage equity capital to Korean technology startups across semiconductors, AI/ICT, and bio/healthcare sectors, managing 844,800+ KRW Million in AUM across 350+ portfolio companies.
- Company typePrivate
- Founded2006
- HeadquartersSeoul, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingServices
What L&S Venture Capital does
L&S Venture Capital (엘앤에스벤처캐피탈 주식회사) is a Seoul-based venture capital firm established in 2006 that provides early-stage equity capital and strategic support to Korean technology startups. The firm invests across three named verticals: SEMI & MCE (semiconductors, materials, components, equipment), AICBM (AI, IoT, Cloud, Big Data, Mobile & Network), and BIO & HEALTH-CARE (medicine, medical devices, e-healthcare). With 18 investment professionals managing 844,800+ KRW Million in assets under management, the firm has built a portfolio of 350+ companies and achieved 85+ successful exits over its two-decade operating history.
The firm operates a traditional venture capital revenue model, earning management fees on assets under administration and carried interest from portfolio company exits. Deal flow is sourced primarily through direct engagement with the Korean startup ecosystem, with the firm positioning itself as 'The First Believer' — providing capital to visionary entrepreneurs ahead of mainstream acceptance. Distribution is direct equity investment into portfolio companies; there is no technology product, platform, or software offering operated by L&S itself. In January 2026, the firm led a $5 million Pre-Series A round in Coxwave (AI product analytics) alongside KB Investment, Hyundai Venture Investment, ZERO1NE Ventures, and KDB Capital.
The firm is led by General Partner and Representative Director Dongshik Chang and includes multiple partners, senior managing directors, managing directors, and investment professionals. L&S has implemented Korea's Stewardship Code for institutional investors effective August 1, 2024, and maintains continuously audited annual financial statements (17th–20th periods) filed with Korea's Financial Supervisory Service and audited by Seonghyun Accounting Corporation. Headquarters are at 7F, Haesung B/D, 504 Teheran-ro, Gangnam-gu, Seoul.
L&S Venture Capital firmographics
Firmographics- Name
- L&S Venture Capital
- Legal name
- 엘앤에스벤처캐피탈 주식회사
- Website
- https://lnsvc.co.kr
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- L&S Venture Capital is a Seoul-based venture capital firm established in 2006 that provides early-stage equity capital to Korean technology startups across semiconductors, AI/ICT, and bio/healthcare sectors, managing 844,800+ KRW Million in AUM across 350+ portfolio companies.
- Ownership category
- akta.pro rank
L&S Venture Capital industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
- akta.pro secondary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where L&S Venture Capital is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
L&S Venture Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Others
Revenue model
- Investment Management Fees and Carried Interest: As a venture capital firm, L&S generates revenue through management fees on managed assets under administration and carried interest from successful portfolio company exits.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
L&S Venture Capital product offering
Product offeringCore offering
L&S Venture Capital (엘앤에스벤처캐피탈) is a Korean venture capital firm established in 2006 that provides early-stage equity capital and strategic support to innovative technology startups. The firm manages over 844,800 KRW Million in assets across a portfolio of 350+ companies, with sector focus spanning SEMI & MCE (Semiconductor, Material, Component, Equipment), AICBM (AI, IoT, Cloud, Big Data, Mobile & Network), and BIO & HEALTH-CARE (Medicine, Medical Devices, E-Healthcare). It has achieved 85+ successful exits through direct equity investments sourced primarily via direct networking and referrals.
Product overview
L&S Venture Capital (엘앤에스벤처캐피탈) is a Korean venture capital firm established in 2006. The company does not offer a technology product or service; instead, it provides venture capital investment services including capital deployment to portfolio companies, investment management, and portfolio company support. As such, there are no product offerings, modules, or sub-brands to enumerate.
Differentiator
Problem solved
Functional benefit
Products and services
- Early-Stage Equity Investment
- Portfolio Management and Strategic Advisory
Quantifiable outcome
- 350+ portfolio companies supported
- +1 more outcomes
Companies that use L&S Venture Capital
Customer profileSegments1 record
Ideal customer profiles1 record
L&S Venture Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
L&S Venture Capital partnerships and signals
Strategic signalScale indicators5 records
Recent moves4 records
Expansion highlights4 records
L&S Venture Capital competitors and assessment
Company assessmentDirect peers
- BonAngels Venture Partners: Korean early-stage venture capital firm. Comparable in seed/pre-seed focus and Korean-domestic investment strategy.
- Altos Ventures: Korea-focused early-stage venture capital firm investing in technology startups. Directly comparable in stage focus and Korean market orientation.
- DSC Investment: Korean venture capital and growth equity firm listed on KOSDAQ. Comparable in domestic Korean investment focus across tech and growth stages.
- Hyundai Venture Investment: Corporate venture arm of Hyundai that co-invested with L&S in Coxwave. Directly comparable as a Korean investor in technology and mobility-adjacent startups.
- Kakao Ventures: Major Korean early-stage venture capital firm backed by Kakao. Highly comparable in stage focus (seed/Series A), sector breadth across Korean tech, and deal pace.
- Primer (formerly Primer Sazze): Korean early-stage venture capital firm investing in Korean tech startups. Comparable in stage focus and Korean market orientation.
- KDB Capital: Korean Development Bank's venture capital arm that participated in the Coxwave round with L&S. Comparable as a domestic Korean VC investing across similar sectors and stages.
- KB Investment: Korean venture capital and growth investor that co-invested alongside L&S in Coxwave's Pre-Series A. Comparable in stage focus, Korean market orientation, and institutional LP backing.
Broad incumbents
- SoftBank Ventures Asia: Asia-focused venture capital arm of SoftBank Group with significant Korean operations. Comparable in Korean tech investment focus but operates with substantially larger fund sizes and broader geographic reach.
- Korea Investment Partners: One of Korea's largest venture capital and private equity firms under Korea Investment Holdings. Comparable in domestic Korean focus but operates at significantly larger AUM across more stages and sectors.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
L&S Venture Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
L&S Venture Capital leadership team
Management profileNumber of profiles
Profiles11 records
L&S Venture Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
L&S Venture Capital M&A and investment
M&A and investmentM&A
Investments120 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about L&S Venture Capital
What does L&S Venture Capital do?
L&S Venture Capital (엘앤에스벤처캐피탈) is a Korean venture capital firm established in 2006 that provides early-stage equity capital and strategic support to innovative technology startups. The firm manages over 844,800 KRW Million in assets across a portfolio of 350+ companies, with sector focus spanning SEMI & MCE (Semiconductor, Material, Component, Equipment), AICBM (AI, IoT, Cloud, Big Data, Mobile & Network), and BIO & HEALTH-CARE (Medicine, Medical Devices, E-Healthcare). It has achieved 85+ successful exits through direct equity investments sourced primarily via direct networking and referrals.
Is L&S Venture Capital a public or private company?
L&S Venture Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was L&S Venture Capital founded?
L&S Venture Capital was founded in 2006. It employs 11 to 50 people.
Where is L&S Venture Capital based?
L&S Venture Capital is headquartered in Seoul, South Korea, in the Asia region.
How does L&S Venture Capital make money?
One revenue line is on record: investment Management Fees and Carried Interest.
Who are L&S Venture Capital's main competitors?
Direct peers on record are BonAngels Venture Partners, Altos Ventures, DSC Investment, Hyundai Venture Investment, Kakao Ventures, Primer (formerly Primer Sazze), KDB Capital and KB Investment. Broad incumbents are SoftBank Ventures Asia and Korea Investment Partners.
Does L&S Venture Capital have an API?
No public API is recorded for L&S Venture Capital.
What industry is L&S Venture Capital in?
L&S Venture Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.